Search

Your search keyword '"M Inagaki"' showing total 449 results

Search Constraints

Start Over You searched for: Author "M Inagaki" Remove constraint Author: "M Inagaki" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
449 results on '"M Inagaki"'

Search Results

1. Development of non-destructive isotope measurement of the natural galena (PbS) using negative muon beams

2. Adjuvants used in fungicide spraying on soybean plants

4. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

6. The noble gas and nitrogen relationship between Ryugu and carbonaceous chondrites

7. Gas Exchanges and Dehydration in Different Intensities of Conditioning in Tifton 85 Bermudagrass: Nutritional Value during Hay Storage

11. A proposed radar method for non-destructive investigation of Egyptian pyramids

12. Molecular diversity and the fate of biochemical fractions of eucalypt tissues in soil

13. Microscale spatial distribution and soil organic matter persistence in top and subsoil

17. Characteristics and suppression of vibration in cross-flow turbine with a cavity

18. Surface Modification of PLA Nanofibers for Coating with Calcium Phosphate

19. Design and Applications of Multi-Frequency Holographic Subsurface Radar: Review and Case Histories

20. P2725Transthyretin cardiac amyloidosis in heart failure with preserved ejection fraction: Imaging by Tc-99m bone scan

21. Development of performance assessment models for glass dissolution

24. A Hologram Reconstruction Algorithm for Landmine Recognition and Classification Based on Microwave Holographic Radar Data

25. P4701The elusive role of myocardial perfusion imaging for the patients with insufficient fractional flow reserve after drug eluting stent implantation

26. Proposal of coherent Cherenkov radiation matched to circular plane wave for intense terahertz light source

27. Element-sensitive computed tomography by fine tuning of PXR-based X-ray source

28. Poster Session 1: Sunday 3 May 2015, 08:30-18:00 * Room: Poster Area

29. 4779Myocardial uptake of bone scintigraphic agents associated with cardiac amyloidosis in daily practice

30. FRI0673 Clinical remission in tocilizumab-using rheumatoid arthritis patients can be overestimated: a cross sectional study using ultrasound sonography

31. MW holographic imaging system for detection of hidden dinosaur tracks

33. Clinical Implication of lymph node dissection for intrahepatic cholangiocarcinoma: a multicenter analysis of 385 resected cases

37. Evaluation of irradiation effects of near-infrared free-electron-laser of silver alloy for dental application

38. Comparison of ROC curves for landmine detection by holographic radar with ROC data from other methods

39. A test of holographic radar for detection of hidden vertebrate tracks and trackways

41. Abstract P4-02-04: Using ultrasound findings to predict high tumor-infiltrating lymphocytes in triple negative breast cancer

42. Project on the superposition of beamlines for parametric X-ray radiation and coherent transition radiation in the THz region at LEBRA

43. FRI0098 A Certain Portion of Active Established Rheumatoid Arthritis Patients with Significant Joint Destruction Are Misclassified as Being in Boolean Remission: A Cross-Sectional Study Using Ultrasound Sonography

44. 1853 Phase I study of combination therapy with weekly nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with advanced or recurrent breast cancer

46. Quantification of gimeracil, tegafur, and 5-FU in human plasma via LC-MS/MS with a simplified pretreatment using flow-through extraction.

47. Outcomes of Combined Atezolizumab Plus Chemotherapy in Non-small Cell Lung Cancer Patients in Clinical Practice.

48. Late-onset disseminated BCG infection with hepatosplenomegaly after intravesical BCG immunotherapy in a non-immunocompromised patient.

49. Paroxysmal delta waves of awake EEG in childhood adrenoleukodystrophy: Possible indicator of the hematopoietic stem cell therapy (HSCT).

50. A Phase 1/2 study of teclistamab, a humanized BCMA × CD3 bispecific Ab in Japanese patients with relapsed/refractory MM.

Catalog

Books, media, physical & digital resources